Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (21,678)	$ (27,300)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	184,536	155,889
Loss (gain) on Disposal or Impairment	7,119	(2,125)
Earnings from equity method investments	(35,711)	(41,493)
Distributions from equity method investments	35,700	41,489
Amortization of debt issuance costs and discount	7,396	5,628
Deferred tax expense (benefit)	(21,494)	1,793
Non-cash equity compensation	7,764	8,332
Provision for uncollectible accounts receivable, net of recoveries	(128)	(97)
Foreign currency transaction loss (gain)	(476)	4,625
Inventory Write-down	2,834	0
Changes in operating assets and liabilities (Note 16)	(31,143)	(10,326)
Net cash provided by operating activities	134,719	136,415
Capital expenditures	(288,939)	(303,391)
Proceeds from sale of long-lived assets	12,817	246
Contributions to equity method investments	(25,456)	(7,466)
Payments to Acquire Businesses, Net of Cash Acquired	(488,297)	0
Proceeds from business divestitures	0	146,735
Distributions in excess of equity in earnings of affiliates	15,838	15,730
Net cash used in investing activities	(774,037)	(148,146)
Debt issuance costs	(13,241)	(4,720)
Borrowings on credit facilities and issuance of senior notes, net of discount	600,104	1,139,500
Principal payments on credit facilities and other obligations	(394,965)	(1,376,649)
Proceeds from Issuance of Common Stock	448,443	0
Proceeds from subsidiary preferred stock issuance, net of offering costs	223,280	342,299
Proceeds from Noncontrolling Interests	103,691	0
Payments to Noncontrolling Interests	(90,830)	0
Repurchase of common stock for payment of statutory taxes due on equity-based compensation	(736)	(699)
Payments of Dividends	(112,929)	(111,445)
Proceeds from issuance of common stock under employee stock purchase plan	523	228
Net cash provided by (used in) financing activities	763,340	(11,486)
Effect of exchange rate changes on cash and cash equivalents	3,330	(494)
Change in cash and cash equivalents	127,352	(23,711)
Cash and cash equivalents at beginning of period	86,655	93,699
Cash and cash equivalents at end of period	$ 214,007	$ 69,988